AstraZeneca's Imfinzi Flunks Late-Stage Head and Neck Cancer Trial - BioSpace

AstraZeneca's Imfinzi Flunks Late-Stage Head and Neck Cancer Trial  BioSpace

AstraZeneca and its MedImmune division announced results from its Phase III EAGLE clinical trial. Imfinzi, in combination with tremelimumab, an anti-CTLA4 ...

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2zQ2GsN